Inflammatory Linear Verrucous Epidermal Nevus Responsive to 308-nm Excimer Laser Treatment by Grgurich, Elise, DO et al.
Lehigh Valley Health Network
LVHN Scholarly Works
Department of Medicine
Inflammatory Linear Verrucous Epidermal Nevus
Responsive to 308-nm Excimer Laser Treatment
Elise Grgurich DO
Lehigh Valley Health Network, elise.grgurich@lvhn.org
Ryan Owen DO
Lehigh Valley Health Network
Joshua M. Levin MD
Lehigh Valley Health Network, Joshua_M.Levin@lvhn.org
Stephen M. Purcell DO
Lehigh Valley Health Network, Stephen.Purcell@lvhn.org
Follow this and additional works at: http://scholarlyworks.lvhn.org/medicine
Part of the Medical Sciences Commons
This Poster is brought to you for free and open access by LVHN Scholarly Works. It has been accepted for inclusion in LVHN Scholarly Works by an
authorized administrator. For more information, please contact LibraryServices@lvhn.org.
Published In/Presented At
Grgurich, E., Owen, R., Levin, J., & Purcell, S. (2016, March 18). Inflammatory Linear Verrucous Epidermal Nevus Responsive to 308-nm
Excimer Laser Treatment. Poster presented at: Philadelphia Dermatological Society Grand Rounds, Philadelphia, PA.
Grgurich, E., Owen, R., Levin, J., & Purcell, S.. (2016, April 26). Inflammatory Linear Verrucous Epidermal Nevus Responsive to 308-nm
Excimer Laser Treatment. Poster presented at LVHN Department of Medicine Research Day, Lehigh Valley Health Network,
Allentown, PA.
Lehigh Valley Health Network, Allentown, Pennsylvania
Elise Grgurich, DO, Ryan Owen, DO, Joshua M. Levin, MD, and Stephen M. Purcell, DO
Case Presentation:
Inflammatory Linear Verrucous Epidermal Nevus Responsive to 308-nm Excimer Laser Treatment
Discussion:
Inflammatory linear verrucous epidermal nevus (ILVEN) was first described by Altman and Mehregan in 1971 as a rare linear 
and pruritic psoriasiform plaque that most commonly presents during childhood. Epidermal nevi may derive from keratinocytic, 
follicular, sebaceous, apocrine, or eccrine origin. ILVEN is classified under the keratinocytic type and represents approximately 
6% of all epidermal nevi.  ILVEN can be a single lesion or multiple unilateral, erythematous, and verrucous plaques along the 
lines of Blaschko. There is a predilection for the lower extremities with girls being four times more commonly affected than 
boys. Cases are predominately sporadic, although rare familial cases have been reported. 
The pathogenesis is largely unknown, however it is believed to represent a clonal dysregulation of keratinocytes exhibiting 
genetic mosaicism. Compared to lesions of psoriasis, ILVEN exhibits less Ki-67 positive keratinocyte nuclei and more 
cytokeratin 10 (CK10) positive cells. Ki-67 is a proliferative marker and CK10 is an epidermal differentiation marker. ILVEN 
demonstrates less CD4+, CD8+, CD45RO+, CD2+, CD25+, CD94+, and CD161+ cells within the dermis and epidermis than 
psoriasis.  
The histopathology of ILVEN reveals epidermal rete elongation, similar to psoriasis, with columns of alternating orthokeratosis 
overlying hypergranulosis and parakeratosis overlying agranulosis. Focal areas of spongiosis may be present. Within the upper 
dermis there is commonly a mild perivascular lymphohistiocytic inflammatory infiltrate. 
ILVEN has been historically refractive to treatment. First line therapies include topical agents such as corticosteroids, 
calcipotriol, retinoids, and 5-fluorouracil. Other treatments include intralesional corticosteroids, cryotherapy, electrodessication 
and curettage, and surgical excision. Several cases report promising results with pulsed dye laser (585 nm) and ablative CO2 
laser (10,600 nm, fractional and super pulsed), however these were unsuccessful in our case. 
Excimer laser has not been published in the literature for treatment of ILVEN, though many studies have demonstrated the 
usefulness of excimer in psoriasis. We propose that secondary to the shared histopathology between ILVEN and psoriasis, 
excimer laser would be successful in the treatment of ILVEN lesions. The 308 nm excimer laser penetrates the epidermal cells 
and fibroblasts inducing T-cell apoptosis making it an effective treatment modality for inflammatory conditions. Currently, our 
patient has undergone ten sessions of UVB excimer laser treatment with significant improvement in lesions. Treatment has 
been well tolerated with no reported side effects.
© 2016 Lehigh Valley Health Network
Patient: 20 year-old Caucasian female. 
History of Present Illness: The patient complains of 
itchy, dry, pink lesions on her right leg since she was 2 weeks old. 
Symptoms have improved slightly with topical treatments, but she 
believes the lesions appear unchanged. She was treated with a short 
course of oral doxycycline following a positive bacterial wound culture 
of the right leg, however experienced no improvement clinically. The 
superior right leg plaque was treated with the super pulsed CO2 laser 
and the inferior right leg plaque was treated with the fractional CO2 
laser with minimal improvement. A trial of UVB excimer laser with ten 
treatments to the right lower leg was then used on the lesions and 
produced significant clinical results. 
Medical/ Surgical History: Acne
Family History: Diabetes, coronary artery disease, negative 
for psoriasis
Social History: Single, college student, denies tobacco use
Current Medications: Benzoyl peroxide 5% facial wash, 
adapalene/benzoyl peroxide topical 0.3%/2.5% gel, norethindrone/
ethinyl estradiol 1.5mg/30mcg 
Previous Medications: Fluoruracil 5%, doxycycline, 
clobetasol proprionate 0.05% cream
Physical Examination: The patient had a few oval 
discrete hyperkeratotic scaly pink plaques on the right lateral leg with 
a hyperkeratotic linear pink plaque extending from the popliteal fossa 
to the posterior thigh. Her nails, scalp, and extensor extremities are 
clear. 
Laboratory Data: (2/5/13) Bacterial culture right leg: 3+ 
staph aureus
Biopsy: Advanced Dermatology Associates, LTD (AD13-
01367, 2/5/2013) Right popliteal fossa: “Psoriasiform dermatitis. 
There is marked uneven psoriasiform hyperplasia with a slightly 
verruciform surface, broad zones of superficial pallor, parakeratosis 
with conspicuous colonies of bacteria, a single incipient subcorneal 
spongiform pustule, spongiosis, focal hypergranulosis, vascular 
ectasias and vertical collagen streaking in dermal papillae, and a 
superficial perivascular and interstitial infiltrate of lymphocytes and 
plasma cells. A PAS is negative for fungus.”
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Figure 1 (10x): Uneven psoriasiform hyperplasia with 
a slightly verruciform surface, broad zones of superficial 
pallor, parakeratosis, focal hypergranulosis, vascular 
ectasias and superficial perivascular and interstitial 
infiltrate of lymphocytes and plasma cells.
Figure 2: Pretreatment clinical appearance of lesion 
demonstrating discrete hyperkeratotic scaly pink 
plaques on the right lateral leg.
Figure 3: Posttreatment with excimer laser 
demonstrating improvement in hyperkeratotic scale and 
mild improvement in erythema.  
